Alnylam Pharmaceuticals, Inc. (NQ:ALNY)
Delayed: 28.98 +0.92 (3.28%)
Trade Now!
Previous Close $28.06    52 Week High $29.00 
Open $28.84    52 Week Low $9.78 
Day High $29.07    P/E N/A 
Day Low $28.47    EPS $-2.01 
Volume 15,819       

Friends, Peers and Foes (?): SNY, KNBWY, SAN, MDCO, ISIS (more...)

May 24, 2013 07:17 AM Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy
May 21, 2013 04:00 PM Alnylam to Webcast Presentation at Deutsche Bank 38th Annual dbAccess Health Care Conference
May 17, 2013 08:03 AM Alnylam (ALNY) Updates on Preclinical Data for RNAi Program Targeting ALAS-1
May 17, 2013 08:00 AM Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria
May 15, 2013 04:00 PM Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference
May 8, 2013 04:00 PM Alnylam to Webcast Presentation at 2013 Bank of America Merrill Lynch Health Care Conference
May 7, 2013 05:02 PM Form 10-Q ALNYLAM PHARMACEUTICALS, For: Mar 31
May 6, 2013 04:09 PM Form 8-K ALNYLAM PHARMACEUTICALS, For: May 06
May 6, 2013 04:01 PM Alnylam Pharmaceuticals, Inc. (ALNY) Posts Q1 Loss of 15c/Share
May 6, 2013 04:00 PM Alnylam Pharmaceuticals Reports First Quarter 2013 Financial Results
View All Articles

Entities mentioned with ALNY

View All Entities